Skip to main content

Table 2 Current and past year treatment

From: Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont

Variable

All participants

(n = 150)

Stimulants main drug

(n = 72)

Opioids main drug

(n = 56)

Stimulants and opioids main drug

(n = 17)

p value

N

%

N

%

N

%

N

%

Current treatment

None

52

34.7

20

27.8

23

41.1

7

41.2

.263

Methadone

50

33.3

24

33.3

20

35.7

6

35.3

.957

Buprenorphine/Suboxone

37

24.7

24

33.3

9

16.1

1

5.9

.016*

Outpatient

23

15.3

14

19.4

7

12.5

2

11.8

.589

12-step/recovery group

1

0.7

1

1.4

0

0.0

0

0.0

.999

Past year treatment

None

32

21.3

14

19.4

11

19.6

5

29.4

.640

Methadone

66

44.0

26

36.1

32

57.1

8

47.1

.059

Buprenorphine/Suboxone

50

33.3

29

40.3

13

23.2

5

29.4

.119

Outpatient

24

16.0

16

22.2

7

12.5

1

5.9

.192

Inpatient

15

10.0

6

8.3

6

10.7

3

17.6

.502

12-step/recovery group

2

1.3

2

2.8

0

0.0

0

0.0

.614

  1. *p < .05